LHSS features four poster presentations at 24th International AIDS Conference.

This report is a health system assessment focused on HIV care services for Venezuelan migrants living in Peru. The assessment reviews secondary data sources; interviews with key informants, users, and professionals who are responsible for health facilities providing Antiretroviral Therapy (HF ART); observes visits to selected HF ART; and provides an overview of a self-administered survey to those responsible for HF ART in the country.

En este informe, LHSS evalúa la demanda de productos básicos para el VIH necesarios para brindar una cobertura adecuada a los venezolanos que viven con el VIH en Perú y analiza los sistemas de pronóstico existentes en el Ministerio de Salud para determinar su precisión en la adquisición y el seguimiento de la distribución de medicamentos clave para el VIH.

In this report, LHSS quantifies the demand for HIV commodities needed to provide adequate coverage for Venezuelans living with HIV in Peru and analyzes existing forecasting systems at the MOH to determine its accuracy in procuring and monitoring the distribution of key HIV drugs.

LHSS tiene como objetivo fortalecer la capacidad del Ministerio de Salud para garantizar la disponibilidad de productos para el VIH (ARV y dispositivos médicos) para la población migrante venezolana en Perú. Como parte de este esfuerzo, LHSS estimó la demanda de productos relacionados con el VIH relacionados con esta población, incluidos detalles como el tipo, la cantidad y el momento. 

This report provides a summary of the results of the quantification of demand for HIV commodities for the Venezuelan migrant population in Peru. It includes the capabilities and limitations of the quantification model, its approach to quantification, and the sources used.

Vietnam is one of the 30 countries with the highest burden of TB and drug-resistant TB in the world, with more than 172,000 cases and 10,400 deaths from TB in Vietnam in 2020 (WHO).  On July 1, TB treatment facilities nationwide started providing TB drugs to patients through social health insurance, marking an important milestone for financial sustainability.

This report presents findings from LHSS Vietnam's international review of diagnosis-related group contracts and provides a series of evaluations and recommendations.

This rapid assessment aimed to determine which health facilities in seven high-TB burden provinces of Vietnam meet social health insurance (SHI) requirements for TB service provision and for reimbursement of TB services through the SHI scheme.

This report provides a review of international experience to draw out practical and scientific approaches for both the Ministry of Health (MOH) and Vietnam Social Security (VSS) to consider. Conclusions and recommendations are provided.

Lhss prepared this report, discussing procurement and payment considerations related to the transition of first-line tuberculosis (TB) drug procurement in Vietnam from the central state budget to the social health insurance fund starting in 2022.

Conducted by LHSS, this market analysis examines four factors affecting SHI-covered ARV procurement and supply in Vietnam, and it also summarizes findings and recommendations across each of these factors.

This document provides a roadmap for Vietnam’s National Tuberculosis (TB) Program to transition procurement and payment for TB drugs to the country’s social health insurance scheme.

This report summarizes the results of a review of international experience and best practices related to pro-health excise taxes.

LHSS in this report recommends that the government raise pro-health excise taxes at greater rates than currently proposed by the Ministry of Finance in order to increase the revenue raised.